Latest Articles
- The role of aldosterone receptor antagonists in the management of heart failure: An update
Spironolactone (Aldactone) and eplerenone (Inspra) are now part of standard therapy. Still, they must be used cautiously, as they can cause hyperkalemia.
- The apples and oranges of cost-effectiveness: A rejoinder
A recent CCJM commentary used straw men to indict cost-effectiveness research.
- Genetic counselors: Your partners in clinical practice
As our understanding of the human genome has grown, so too has the need for health care providers to help patients and families understand the implications of these discoveries.
- Distinguishing cellulitis from its mimics
Common imitators are stasis dermatitis, lipodermatosclerosis, contact dermatitis, lymphedema, eosinophilic cellulitis, and papular urticaria.
- Atrial fibrillation: New drugs, devices, and procedures
An update on controversies in treating atrial fi brillation: new oral anticoagulants vs warfarin, rate control vs rhythm control, the safety of dronedarone, and the efficacy of ablation.
- Synthetic legal intoxicating drugs
Readers comment on synthetic legal intoxicating drugs (April 2012) and on the geriatric patient-centered medical home (May 2012).
- In reply: Geriatric patient-centered medical home
Readers comment on synthetic legal intoxicating drugs (April 2012) and on the geriatric patient-centered medical home (May 2012).
- The stethoscope as metaphor
The humanities—and bedside skills—ought to be a fundamental part of medical education. The alternative is a future full of technicians with tricorders, but sorely lacking in healers.
- Regularizing the approach to the irregularly irregular
We have more choices, more data, and more management algorithms, but still no panacea for atrial fibrillation.